惯性聚合 高效追踪和阅读你感兴趣的博客、新闻、科技资讯
阅读原文 在惯性聚合中打开

推荐订阅源

Google DeepMind News
Google DeepMind News
爱范儿
爱范儿
J
Java Code Geeks
L
LangChain Blog
V
V2EX
大猫的无限游戏
大猫的无限游戏
S
SegmentFault 最新的问题
博客园 - Franky
Microsoft Azure Blog
Microsoft Azure Blog
Jina AI
Jina AI
Blog — PlanetScale
Blog — PlanetScale
奇客Solidot–传递最新科技情报
奇客Solidot–传递最新科技情报
The Cloudflare Blog
博客园 - 司徒正美
B
Blog
G
Google Developers Blog
Stack Overflow Blog
Stack Overflow Blog
罗磊的独立博客
OSCHINA 社区最新新闻
OSCHINA 社区最新新闻
Apple Machine Learning Research
Apple Machine Learning Research
Engineering at Meta
Engineering at Meta
MyScale Blog
MyScale Blog
有赞技术团队
有赞技术团队
Hugging Face - Blog
Hugging Face - Blog

All Articles on Seeking Alpha

All Eyes On Cencora, A Healthcare Supplier That Could See Lots More Upside Simply Good Foods Doesn't Look Like A Growth Stock Anymore Applied Digital: Post-Earnings Clarity Confirms An Accelerated Path To $1 Billion NOI Target IBIT: Why I Stepped To The Side (Technical Analysis) (Rating Downgrade) XES: Oil Service Stocks Turn Pricey; Why It's Time To Take Profits (Rating Downgrade) The Only Dividend Strategy I'd Trust In A 3.5% Fed Funds World Opera: AI-Driven Advertising Prospects - Upside Potential And Rich Dividend Yields RenaissanceRe: Preferred Stock Hasn't Been This Appealing In Years Q1 Earnings Kick Off With Major Banks' Results: Bank of America, Netflix In Focus Sezzle: Consolidation Completed, Re-Rating Ahead Bitmine Immersion Q2 Preview: Ethereum Thesis Facing Important Report Card I Am Sharing 2 Of My Retirement High-Yield Gems The Software Narrative Is Leaking Badly Again Thanks To Anthropic Mythos The Muni Market Looks Appealing In Q2 AVIV: Should Keep Rising If The Ceasefire Holds Foundayo Explained: Lilly's New Weight Loss Pill And The Amazon Effect Sabesp: A New Privatization As An Opportunity! EchoStar: Potential Bull Trap At Play - Take Gains Off The Table Teladoc Health: Improving Fundamentals Support A Turnaround Story March CPI Inflation: 5 Reasons To Stay Calm Two 12%+ Yielding BDC Bargains (One Is My Top Deep-Value Pick) TechnipFMC: We Prefer Saipem With More Room To Improve Tesla: From Bye-Bye To Buy-Buy (Rating Upgrade) DMB: Vulnerable To High Interest Rates Western Midstream: A 9% Yield That Still Grows In A Downturn IQQQ: Tax-Efficient Income From The Nasdaq But Does Not Protect Against Declines Qualys Share Price Pulled Down By Potential Cybersecurity Disruptor S&P 500: A Dead Money Era May Be Here. How To Thrive In It Vistance Networks Looks Better Than Before With Powerful Earnings Growth Commerce Bancshares: Valuation, Not Quality, Is The Problem
Neurocrine Biosciences, Inc. (NBIX) Q1 2026 Earnings Call...
SA Transcripts · 2026-05-06 · via All Articles on Seeking Alpha

Q1: 2026-05-05 Earnings Summary

EPS of $1.94 beats by $0.24

 | 

Revenue of

$814.50M

(42.25% Y/Y)

beats by $46.62M

Neurocrine Biosciences, Inc. (NBIX) Q1 2026 Earnings Call May 5, 2026 4:30 PM EDT

Company Participants

Todd Tushla - Vice President of Investor Relations
Kyle Gano - President, CEO & Director
Matthew Abernethy - Chief Financial Officer
Eric Benevich - Chief Commercial Officer
Sanjay Keswani - Chief Medical Officer

Conference Call Participants

Tazeen Ahmad - BofA Securities, Research Division
Paul Matteis - Stifel, Nicolaus & Company, Incorporated, Research Division
Brian Abrahams - RBC Capital Markets, Research Division
Cory Kasimov - Evercore ISI Institutional Equities, Research Division
Corinne Jenkins - Goldman Sachs Group, Inc., Research Division
Philip Nadeau - TD Cowen, Research Division
Brian Skorney - Robert W. Baird & Co. Incorporated, Research Division
Anupam Rama - JPMorgan Chase & Co, Research Division
Jay Olson - Oppenheimer & Co. Inc., Research Division
Myles Minter - William Blair & Company L.L.C., Research Division
So Youn Shim - UBS Investment Bank, Research Division
Basma Radwan Ibrahim - Leerink Partners LLC, Research Division
Susan Chor - Wells Fargo Securities, LLC, Research Division
Poorna Kannan - Needham & Company, LLC, Research Division
David Amsellem - Piper Sandler & Co., Research Division
Yigal Nochomovitz - Citigroup Inc., Research Division
Sumant Kulkarni - Canaccord Genuity Corp., Research Division
Yatin Suneja - Guggenheim Securities, LLC, Research Division
Danielle Brill Bongero - Truist Securities, Inc., Research Division
Laura Chico - Wedbush Securities Inc., Research Division
Samuel Beck - Deutsche Bank AG, Research Division
Guofang Li - Wolfe Research, LLC
Malcolm Hoffman - BMO Capital Markets Equity Research

Presentation

Operator

Hello, and welcome, everyone joining today's Neurocrine Biosciences' Q1 2026 Earnings Call. [Operator Instructions] Please note, this call is being recorded. [Operator Instructions]

It is now my pleasure to turn the meeting over to Todd Tushla, Vice President of Investor Relations. Please go ahead.

Todd Tushla
Vice President of Investor Relations

Thank you, and happy Cinco de Mayo to everyone. Welcome to Neurocrine Biosciences' First Quarter 2026 Earnings Call. Joining me today are Kyle Gano, Chief Executive Officer; Matt Abernethy, Chief